(Q43478484)

English

Preclinical evaluation of BAY 1075553, a novel (18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer

scientific article published on 17 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Preclinical evaluation of BAY 1075553, a novel (18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

author name string

Ralf Lesche

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Georg Kettschau

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Alexey V Gromov

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Niels Böhnke

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sandra Borkowski

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Ursula Mönning

6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Christa Hegele-Hartung

7

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Olaf Döhr

8

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Ludger M Dinkelborg

9

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Keith Graham

10

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

publication date

17 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

89-101

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

https://scigraph.springernature.com/pub.10.1007/s00259-013-2527-3

0 references

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

[(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Prostate-specific membrane antigen: present and future applications

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Radionuclide based imaging of prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Radiofluorinated derivatives of 2-(phosphonomethyl)pentanedioic acid as inhibitors of prostate specific membrane antigen (PSMA) for the imaging of prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Physical models and dose factors for use in internal dose assessment

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Decay data for internal and external dose assessment

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Suitability of commonly used excipients for electrophysiological in-vitro safety pharmacology assessment of effects on hERG potassium current and on rabbit Purkinje fiber action potential

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

In vitro safety pharmacology profiling: what else beyond hERG?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

QTc shortening with a new investigational cancer drug: a brief case study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Immunocytochemical distribution of N-acetylaspartylglutamate in the rat forebrain and glutamatergic pathways

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

123I-MIP-1072, a small-molecule inhibitor of prostate-specific membrane antigen, is effective at monitoring tumor response to taxane therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Decreased replication ability of E1-deleted adenoviruses correlates with increased brain tumor malignancy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Production of multimeric prostate-specific membrane antigen small-molecule radiotracers using a solid-phase 99mTc preloading strategy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

4-[18F]fluoroglutamic acid (BAY 85-8050), a new amino acid radiotracer for PET imaging of tumors: synthesis and in vitro characterization.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

[Diagnostic relevance of choline-PET / CT in patients with prostate cancer].

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2527-3

21 January 2018

Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific membrane antigen expression in normal and malignant human tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A tabulated summary of the FDG PET literature.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promising tumor-associated antigens for future prostate cancer therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-013-2527-3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

release_rurvrfbsjza37lrjx73vsdwscm

1 reference

https://api.fatcat.wiki/v0/release/rurvrfbsjza37lrjx73vsdwscm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43478484&oldid=1989655778"